cobas® SARS-CoV-2 & Influenza A/B Test

Cureus, Laboratory and Point-of-Care Testing for COVID-19: A Review of Recent Developments

ID™SARS-Cov-2 / Influenza Triplex, is a ready-to-use RT-PCR kit.

Multi-center nationwide comparison of seven serology assays reveals a SARS- CoV-2 non-responding seronegative subpopulation - eClinicalMedicine

Agile design and development of a high throughput cobas SARS-CoV-2 RT-PCR diagnostic test - ScienceDirect

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay

FDA warns of potential false positive results with Roche Cobas rapid coronavirus, flu test

Roche su LinkedIn: SARS-CoV-2 & Flu A/B Rapid Antigen Test

SARS-CoV-2 detection using reverse transcription strand invasion based amplification and a portable compact size instrument

cobas® SARS-CoV-2 & Influenza A/B v2, Qualitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems

SARS-CoV-2 & Flu A/B Rapid Antigen Test​

Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR

The cobas SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test

Roche Diagnostics cobas Liat SARS-CoV-2 + Influenza A/B Multiplex Assay